"Neoplasms, Experimental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.
| Descriptor ID |
D009374
|
| MeSH Number(s) |
C04.619 E05.598.500.496
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms, Experimental".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms, Experimental".
- Neoplasms, Experimental
- Carcinoma 256, Walker
- Carcinoma, Brown-Pearce
- Carcinoma, Ehrlich Tumor
- Carcinoma, Krebs 2
- Carcinoma, Lewis Lung
- Leukemia, Experimental
- Liver Neoplasms, Experimental
- Mammary Neoplasms, Experimental
- Melanoma, Experimental
- Sarcoma, Experimental
This graph shows the total number of publications written about "Neoplasms, Experimental" by people in this website by year, and whether "Neoplasms, Experimental" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 8 | 14 | 22 |
| 2018 | 18 | 7 | 25 |
| 2019 | 5 | 1 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Neoplasms, Experimental" by people in Profiles.
-
Dual Inhibition of GLUT1 and the ATR/CHK1 Kinase Axis Displays Synergistic Cytotoxicity in KRAS-Mutant Cancer Cells. Cancer Res. 2019 Oct 01; 79(19):4855-4868.
-
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer. Cancer Res. 2019 08 15; 79(16):4196-4210.
-
Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth. Nat Immunol. 2019 03; 20(3):257-264.
-
Chronic retroviral infection of mice promotes tumor development, but CD137 agonist therapy restores effective tumor immune surveillance. Cancer Immunol Immunother. 2019 Mar; 68(3):479-488.
-
Photo-Cured Glycol Chitosan Hydrogel for Ovarian Cancer Drug Delivery. Mar Drugs. 2019 Jan 10; 17(1).
-
A systematic review of herbal medicines for the treatment of cancer cachexia in animal models. J Zhejiang Univ Sci B. 2019 Jan.; 20(1):9-22.
-
Photosensitizer-Loaded Multifunctional Chitosan Nanoparticles for Simultaneous in Situ Imaging, Highly Efficient Bacterial Biofilm Eradication, and Tumor Ablation. ACS Appl Mater Interfaces. 2019 Jan 16; 11(2):2302-2316.
-
Sensitive, Real-Time, and In-Vivo Oxygen Monitoring for Photodynamic Therapy by Multifunctional Mesoporous Nanosensors. ACS Appl Mater Interfaces. 2019 Jan 09; 11(1):187-194.
-
Porphyrin-High-Density Lipoprotein: A Novel Photosensitizing Nanoparticle for Lung Cancer Therapy. Ann Thorac Surg. 2019 02; 107(2):369-377.
-
Mitochondrial pyruvate carrier 1 functions as a tumor suppressor and predicts the prognosis of human renal cell carcinoma. Lab Invest. 2019 02; 99(2):191-199.